Stay updated on Pembrolizumab in Platinum Pre-treated Nasopharyngeal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Platinum Pre-treated Nasopharyngeal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab in Platinum Pre-treated Nasopharyngeal Cancer Clinical Trial page
- Check3 days agoChange DetectedThe page’s footer/version indicator has been updated from revision v3.5.2 to v3.5.3, reflecting a site software or release change rather than an update to the clinical trial information.SummaryDifference0.1%

- Check10 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check39 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check75 days agoChange DetectedAdded a new publication reference under Publications: Chan ATC, Lee VHF, Hong RL, et al. Analysis of Plasma Epstein-Barr Virus DNA and Clinical Outcomes to Pembrolizumab or Chemotherapy in Recurrent/Metastatic Nasopharyngeal Cancer in KEYNOTE-122 (Cancer Med. 2026;15(2):e71496, DOI: 10.1002/cam4.71496). The entry notes that publications are auto-filled from PubMed and includes a Revision: v3.4.2.SummaryDifference0.6%

- Check82 days agoChange DetectedAdded a site-wide government funding notice and a new Revision: v3.4.1 tag, and removed the previous Revision: v3.4.0 tag.SummaryDifference0.4%

Stay in the know with updates to Pembrolizumab in Platinum Pre-treated Nasopharyngeal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Platinum Pre-treated Nasopharyngeal Cancer Clinical Trial page.